Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Assets Average of $11.1 million in Q1 2026, up 58.97% quarter-over-quarter from $7.0 million in Q4 2025, and up 185.11% on a YoY basis from $3.9 million in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Assets Average (2022 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Assets Average history runs 5 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- In Q1 2026, Assets Average rose 185.11% year-over-year to $11.1 million; the TTM figure through Mar 2026 stood at $11.1 million (up 185.11% YoY), while the FY2025 annual figure was $6.5 million, up 53.49% from the prior year.
- Assets Average was $11.1 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from $7.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $11.1 million in Q1 2026 to a low of $1.6 million in Q4 2024.
- Historically, Assets Average has averaged $6.2 million across 5 years, with a median of $6.0 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Assets Average plunged 78.5% in 2024, then surged 340.87% in 2025.
- A 5-year view of Assets Average shows it stood at $9.0 million in 2022, then fell by 26.1% to $6.7 million in 2023, then slumped by 76.14% to $1.6 million in 2024, then jumped by 340.87% to $7.0 million in 2025, then jumped by 58.97% to $11.1 million in 2026.
- The last three Assets Average figures came in at $11.1 million (Q1 2026), $7.0 million (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | 11.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.14 Mn |
| Dec 31, 2025 | 7.01 Mn |
| Sep 30, 2025 | 4.52 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 3.91 Mn |
| Dec 31, 2024 | 1.59 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 3.78 Mn |
| Mar 31, 2024 | 5.35 Mn |
| Dec 31, 2023 | 6.66 Mn |
| Sep 30, 2023 | 8.11 Mn |
| Jun 30, 2023 | 9.64 Mn |
| Mar 31, 2023 | 9.55 Mn |
| Dec 31, 2022 | 9.02 Mn |